Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye

Intra-arterial chemotherapy (IAC) has assumed a major role in the management of retinoblastoma. This targeted therapy involves the delivery of chemotherapy directly into the ophthalmic artery, minimizing systemic absorption. We report a case of retinoblastoma regression in the untreated eye followin...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Grace L., Lim, Li-Anne S., Welch, R. Joel, Shields, Carol L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819715/
https://www.ncbi.nlm.nih.gov/pubmed/31686972
http://dx.doi.org/10.1016/j.sjopt.2019.05.007
Descripción
Sumario:Intra-arterial chemotherapy (IAC) has assumed a major role in the management of retinoblastoma. This targeted therapy involves the delivery of chemotherapy directly into the ophthalmic artery, minimizing systemic absorption. We report a case of retinoblastoma regression in the untreated eye following IAC to the contralateral eye.

Ejemplares similares